[Clinical application of local hyperthermia combined with antineoplastic agents]. 1985

J Ishiwata, and T Sasaki, and S Iwamoto, and M Koike, and Y Maeda, and Y Takeshita, and Y Tanaka, and T Masuda

At present hyperthermia shows great promise when combined with other modalities. Local thermo-chemotherapy may also be a very attractive research field, but the combination of hyperthermia and anti-cancer drugs is still poorly understood. In this review, the background and the clinical reports on heat and chemotherapy which have been reported during the last year were analyzed. Finally, our clinical experiences with local hyperthermia combined with anti-cancer drugs for gastrointestinal cancer were also reported.

UI MeSH Term Description Entries
D006979 Hyperthermia, Induced Abnormally high temperature intentionally induced in living things regionally or whole body. It is most often induced by radiation (heat waves, infra-red), ultrasound, or drugs. Fever Therapy,Hyperthermia, Local,Hyperthermia, Therapeutic,Thermotherapy,Induced Hyperthermia,Therapeutic Hyperthermia,Therapy, Fever,Local Hyperthermia
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008937 Mitomycins A group of methylazirinopyrroloindolediones obtained from certain Streptomyces strains. They are very toxic antibiotics used as ANTINEOPLASTIC AGENTS in some solid tumors. PORFIROMYCIN and MITOMYCIN are the most useful members of the group.
D001831 Body Temperature The measure of the level of heat of a human or animal. Organ Temperature,Body Temperatures,Organ Temperatures,Temperature, Body,Temperature, Organ,Temperatures, Body,Temperatures, Organ
D002945 Cisplatin An inorganic and water-soluble platinum complex. After undergoing hydrolysis, it reacts with DNA to produce both intra and interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with cellular arrest in the G2 phase of the cell cycle. Platinum Diamminodichloride,cis-Diamminedichloroplatinum(II),cis-Dichlorodiammineplatinum(II),Biocisplatinum,Dichlorodiammineplatinum,NSC-119875,Platidiam,Platino,Platinol,cis-Diamminedichloroplatinum,cis-Platinum,Diamminodichloride, Platinum,cis Diamminedichloroplatinum,cis Platinum
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D005260 Female Females
D005472 Fluorouracil A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid. 5-FU,5-FU Lederle,5-FU Medac,5-Fluorouracil,5-Fluorouracil-Biosyn,5-HU Hexal,5FU,Adrucil,Carac,Efudex,Efudix,Fluoro-Uracile ICN,Fluoroplex,Fluorouracil Mononitrate,Fluorouracil Monopotassium Salt,Fluorouracil Monosodium Salt,Fluorouracil Potassium Salt,Fluorouracil-GRY,Fluorouracile Dakota,Fluorouracilo Ferrer Far,Fluoruracil,Fluracedyl,Flurodex,Haemato-FU,Neofluor,Onkofluor,Ribofluor,5 FU Lederle,5 FU Medac,5 Fluorouracil,5 Fluorouracil Biosyn,5 HU Hexal,Dakota, Fluorouracile,Fluoro Uracile ICN,Fluorouracil GRY,Haemato FU

Related Publications

J Ishiwata, and T Sasaki, and S Iwamoto, and M Koike, and Y Maeda, and Y Takeshita, and Y Tanaka, and T Masuda
February 1982, Nihon rinsho. Japanese journal of clinical medicine,
J Ishiwata, and T Sasaki, and S Iwamoto, and M Koike, and Y Maeda, and Y Takeshita, and Y Tanaka, and T Masuda
November 1983, Cancer,
J Ishiwata, and T Sasaki, and S Iwamoto, and M Koike, and Y Maeda, and Y Takeshita, and Y Tanaka, and T Masuda
January 1972, Gan no rinsho. Japan journal of cancer clinics,
J Ishiwata, and T Sasaki, and S Iwamoto, and M Koike, and Y Maeda, and Y Takeshita, and Y Tanaka, and T Masuda
January 1986, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer,
J Ishiwata, and T Sasaki, and S Iwamoto, and M Koike, and Y Maeda, and Y Takeshita, and Y Tanaka, and T Masuda
September 1970, Gan no rinsho. Japan journal of cancer clinics,
J Ishiwata, and T Sasaki, and S Iwamoto, and M Koike, and Y Maeda, and Y Takeshita, and Y Tanaka, and T Masuda
October 1984, Nihon Gan Chiryo Gakkai shi,
J Ishiwata, and T Sasaki, and S Iwamoto, and M Koike, and Y Maeda, and Y Takeshita, and Y Tanaka, and T Masuda
April 2004, Gan to kagaku ryoho. Cancer & chemotherapy,
J Ishiwata, and T Sasaki, and S Iwamoto, and M Koike, and Y Maeda, and Y Takeshita, and Y Tanaka, and T Masuda
January 1983, Medical physics,
J Ishiwata, and T Sasaki, and S Iwamoto, and M Koike, and Y Maeda, and Y Takeshita, and Y Tanaka, and T Masuda
September 1968, Naika. Internal medicine,
J Ishiwata, and T Sasaki, and S Iwamoto, and M Koike, and Y Maeda, and Y Takeshita, and Y Tanaka, and T Masuda
November 1972, Casopis lekaru ceskych,
Copied contents to your clipboard!